FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/078363 [Registered on: 20/12/2024] Trial Registered Prospectively
Last Modified On: 06/05/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Nirgundi Kashayam and Parijata Kashayam for Sciatica  
Scientific Title of Study   Comparative Pharmacognostical and Clinical Study of Parijata (Nyctanthes arbor-tristis Linn) and Nirgundi (Vitex negundo Linn) as Vedanahara in Gridhrasi with Special Reference to Sciatica. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr. Pola Karthikeya  
Designation  PG Scholar  
Affiliation  Dr. BRKR Government Ayurvedic College  
Address  Dr. BRKR Government Ayurvedic College Opposite ESI Hospital, Towards S R Nagar, AG Colony Road, Sultan Nagar, Erragadda, Hyderabad, Telangana - 500018.

Hyderabad
TELANGANA
500018
India 
Phone  8019339168  
Fax    
Email  developer.beingvaidya@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. S. Baburao  
Designation  Associate professor  
Affiliation  Dr. BRKR Government Ayurvedic College 
Address  Dr. BRKR Government Ayurvedic College Opposite ESI Hospital, Towards S R Nagar, AG Colony Road, Sultan Nagar, Erragadda, Hyderabad, Telangana - 500018.

Hyderabad
TELANGANA
500018
India 
Phone  9885361326  
Fax    
Email  hayagrivavedatarupvtltd@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr. S. Baburao  
Designation  Associate professor  
Affiliation  Dr. BRKR Government Ayurvedic College  
Address  Dr. BRKR Government Ayurvedic College Opposite ESI Hospital, Towards S R Nagar, AG Colony Road, Sultan Nagar, Erragadda, Hyderabad, Telangana - 500018.

Hyderabad
TELANGANA
500018
India 
Phone  9885361326  
Fax    
Email  hayagrivavedatarupvtltd@gmail.com  
 
Source of Monetary or Material Support  
Dr. BRKR Government Ayurvedic College Opposite ESI Hospital, Towards S R Nagar, AG Colony Road, Sultan Nagar, Erragadda, Hyderabad, Telangana - 500018. 
 
Primary Sponsor  
Name  Dr BRKR Government Ayurvedic College  
Address  Opposite ESI Hospital, Towards S R Nagar, AG Colony Road, Sultan Nagar, Erragadda, Hyderabad, Telangana - 500018. 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
Central Council for Research in Ayurvedic Sciences CCRAS  Education Cell, CCRAS, 61-65, opp. D Block, Institutional Area, Janakpuri, New Delhi - 110058 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pola Karthikeya   Dr BRKR Government Ayurvedic College   Dr BRKR Government Ayurvedic College, Department of Dravyaguna, Ground floor OP room no 4, Opp ESI Hospital ,towards S R Nagar, AG Colony Rd, Sultan Nagar, Erragadda, Hyderabad, Telangana 500018
Hyderabad
TELANGANA 
8019339168

developer.beingvaidya@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Government of Telangana Dr. BRKR Government Ayurvedic College, Erragadda, Hyderabad Affiliated to Kaloji Narayana Rao University of Health Sciences, Warangal, Telangana Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:G55||Nerve root and plexus compressionsin diseases classified elsewhere. Ayurveda Condition: GRUDHRASI,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Parijata Kashayam , Reference: Priya Nighantu 80/190, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 50(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 45 Days, anupAna/sahapAna: No, Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Nirgundi Kashayam , Reference: Bhavaprakasha Nighantu 3/113, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 50(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 45 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Age between 20-60 years, irrespective of gender, caste, religion and socioeconomic status were selected for study
Patients suffering with Low back ache radiating to lower limbs
Patients presenting with lakshanas of gridhrasi 
 
ExclusionCriteria 
Details  Patients suffering with below mentioned conditions will be excluded
Uncontrolled Diabetes Mellitus and Hypertension
Loss of bowel and bladder control
Spondylolisthesis
Vertebral Fractures
Foot drop
Psychiatric disorders
Pott’s spine
Post spinal surgical cases
Severe systemic disorders
Malignancy 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
The primary outcome of study is:

Reduction in pain levels in patients with Gridhrasi (Sciatica).

Measured using: Visual Analog Scale (VAS) & other parameters.

 
The time points for the study are as follows:

1. Baseline Assessment:

Conducted on Day 1 before starting the treatment.

2. Duration of Treatment:

The treatment will be administered for 45 days.

3. Patient Reviews:

Patients will be reviewed every 15 days during the treatment period (i.e., on Day 15, Day 30, and Day 45).

4. Follow-Up:

A follow-up assessment will be conducted 30 days after completing the treatment.





 
 
Secondary Outcome  
Outcome  TimePoints 
1) Functional improvement
2) Reduction in inflammation
3) Improvement in Range of motion
4) Patient satisfaction
 
The time points for the study are as follows:

1. Baseline Assessment:

Conducted on Day 1 before starting the treatment.

2. Duration of Treatment:

The treatment will be administered for 45 days.

3. Patient Reviews:

Patients will be reviewed every 15 days during the treatment period (i.e., on Day 15, Day 30, and Day 45).

4. Follow-Up:

A follow-up assessment will be conducted 30 days after completing the treatment. 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial
Modification(s)  
Phase 2/ Phase 3 
Date of First Enrollment (India)   01/01/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   "Comparative Pharmacognostical and Clinical Study of Parijata (Nyctanthes arbor-tristis Linn) and Nirgundi (Vitex negundo Linn) as Vedanahara in Gridhrasi W.S.R to Sciatica", aims to compare the efficacy and safety of two herbal treatments—Parijata (Nyctanthes arbor-tristis) and Nirgundi (Vitex negundo)—in the management of Gridhrasi (Sciatica), which is a common cause of lower back and leg pain.

Study Objectives:

Pharmacognostical Comparison: To analyze the pharmacological properties, active constituents, and quality of the two herbs.

Clinical Comparison: To evaluate the therapeutic effects of Parijata and Nirgundi in treating sciatica symptoms, including pain relief, functional improvement, and quality of life.


Study Design:

A randomized, parallel group, active control trial where participants will be assigned to receive either Parijata, Nirgundi, or a standard treatment.


Primary Outcomes:

Pain reduction using tools like the Visual Analog Scale (VAS)

Functional improvement through disability assessments


Secondary Outcomes:

Reduction in inflammation, assessed by CRP levels.

Improvement in range of motion by SLR TEST

Tracking of adverse effects and patient satisfaction.


Conclusion:

The study will help determine the effectiveness of these two herbal treatments in reducing sciatica symptoms, contributing to the understanding of Ayurvedic therapies in managing Gridhrasi (Sciatica). The findings could provide valuable insights into integrating these herbs as potential treatment options for sciatica in clinical settings.

This study is crucial for advancing knowledge in Ayurvedic pain management and could have significant implications for treating sciatica with natural remedies.


 
Close